scholarly article | Q13442814 |
P50 | author | Steven E. Kahn | Q41640212 |
P2093 | author name string | Q Xiao | |
J Tong | |||
R L Hull | |||
S Zraika | |||
R H Knopp | |||
D B Carr | |||
J S Mistry | |||
T M Wallace | |||
K M Utzschneider | |||
B M Retzlaff | |||
P2860 | cites work | An inflammatory cascade leading to hyperresistinemia in humans | Q24796813 |
The hormone resistin links obesity to diabetes | Q29616100 | ||
Adipose tissue as an endocrine organ | Q29620407 | ||
Correlation between serum resistin level and adiposity in obese individuals | Q33967739 | ||
Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects | Q34311869 | ||
High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians | Q40514603 | ||
Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators | Q44263788 | ||
Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome | Q44995548 | ||
Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes | Q45081266 | ||
Resistin is an inflammatory marker of atherosclerosis in humans. | Q53870894 | ||
P433 | issue | 11 | |
P921 | main subject | metabolic syndrome | Q657193 |
preproinsulin | Q7240673 | ||
P304 | page(s) | 2330-2333 | |
P577 | publication date | 2005-09-06 | |
P1433 | published in | Diabetologia | Q5270140 |
P1476 | title | Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans | |
P478 | volume | 48 |
Q37672876 | Adenylyl cyclase-associated protein 1 is a receptor for human resistin and mediates inflammatory actions of human monocytes |
Q29619393 | Adipocytokines: mediators linking adipose tissue, inflammation and immunity |
Q38935290 | Adipokines in psoriasis: An important link between skin inflammation and metabolic alterations. |
Q39250237 | Adiponectin and Intelectin-1: Important Adipokine Players in Obesity-Related Colorectal Carcinogenesis |
Q33948483 | Adipose tissue and vascular inflammation in coronary artery disease |
Q37340306 | Adipose tissue-mediated inflammation: the missing link between obesity and cardiovascular disease? |
Q37340350 | Adipose tissue: the new endocrine organ? A review article |
Q47220057 | Age-Associated Decline in Dendritic Cell Function and the Impact of Mediterranean Diet Intervention in Elderly Subjects |
Q53305009 | Association between adiponectin, resistin, insulin resistance, and colorectal tumors. |
Q35747118 | Association of Resistin with Insulin Resistance and Factors of Metabolic Syndrome in North Indians. |
Q35245193 | Association of circulating resistin with metabolic risk factors in Indian females having metabolic syndrome |
Q47978333 | CNS Targets of Adipokines |
Q35829203 | Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns |
Q38343028 | EGFL6 is increasingly expressed in human obesity and promotes proliferation of adipose tissue-derived stromal vascular cells. |
Q28469198 | Efficacy of antioxidant treatment in reducing resistin serum levels: a randomized study |
Q40504566 | Epigenome-wide association study suggests that SNPs in the promoter region of RETN influence plasma resistin level via effects on DNA methylation at neighbouring sites. |
Q36665152 | High insulin and leptin increase resistin and inflammatory cytokine production from human mononuclear cells |
Q35087560 | Human resistin: found in translation from mouse to man |
Q46943466 | Increase in serum resistin during weight loss in overweight subjects is related to lipid metabolism. |
Q51472716 | Increased expression of the macrophage markers and of 11beta-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesity. |
Q51498317 | Increased serum resistin in elite endurance athletes with high insulin sensitivity. |
Q36409227 | Inflammatory mechanisms in the regulation of insulin resistance |
Q36582321 | Influence of Obesity and Related Metabolic Alterations on Colorectal Cancer Risk |
Q42145401 | Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells |
Q46165782 | Insulin resistance without obesity induced by cotton pellet granuloma in mice |
Q38985223 | Lymphocytes and macrophages in adipose tissue in obesity: markers or makers of subclinical inflammation? |
Q37377167 | Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation. |
Q36951691 | Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease. |
Q38178783 | Obstructive sleep apnoea and type 2 diabetes mellitus: a bidirectional association |
Q37041935 | Once fat was fat and that was that: our changing perspectives on adipose tissue. |
Q37021597 | Peripheral mononuclear cell resistin mRNA expression is increased in type 2 diabetic women. |
Q38061797 | Peripheral signalling involved in energy homeostasis control |
Q43281626 | Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population. |
Q36830035 | Potential mechanisms of exercise in gestational diabetes |
Q36196397 | Relation of resistin levels with C-reactve protein, homocysteine and uric acid in smokers and non-smokers |
Q64093563 | Relationship between Resistin, Endothelin-1, and Flow-Mediated Dilation in Patient with and without Metabolic Syndrome |
Q36574933 | Relationship between deep subcutaneous abdominal adipose tissue and metabolic syndrome: a case control study |
Q46535425 | Relationship of adipokines (adiponectin, resistin and RBP4) with metabolic syndrome components in pubertal obese children |
Q46745302 | Resistin correlates with elastase and interleukin-6 in human seminal plasma |
Q35025714 | Resistin gene variation is associated with systemic inflammation but not plasma adipokine levels, metabolic syndrome or coronary atherosclerosis in nondiabetic Caucasians |
Q46712922 | Resistin polymorphims, plasma resistin levels and obesity in Tunisian volunteers. |
Q34592168 | Resistin, a new adipokine, is related to inflammation and renal function in kidney allograft recipients. |
Q37621780 | Resistin: a potential biomarker for periodontitis influenced diabetes mellitus and diabetes induced periodontitis. |
Q36271854 | Resistin: yet another adipokine tells us that men are not mice |
Q37497870 | Reviews: adipocytokines in normal and complicated pregnancies |
Q35895869 | Role of adipokines and other inflammatory mediators in gestational diabetes mellitus and previous gestational diabetes mellitus |
Q47734576 | Serum concentrations of resistin and adiponectin and their relationship to insulin resistance in subjects with impaired glucose tolerance |
Q36772021 | Serum resistin and high sensitive CRP levels in patients with subclinical hypothyroidism before and after L-thyroxine therapy |
Q46849188 | Serum resistin is positively correlated with the accumulation of metabolic syndrome factors in type 2 diabetes |
Q41902978 | The +299(G>A) resistin gene polymorphism and susceptibility to type 2 diabetes in Thais |
Q51373468 | The plasma level and gene expression of resistin in polycystic ovary syndrome. |
Q36474596 | The relation of obesity with serum resistin levels in smoker and nonsmokers. |
Q36095970 | The role of adipokines in connective tissue diseases. |
Q34819729 | Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women |
Q51468095 | Within-subject variation of plasma resistin levels over a 1-year period. |
Search more.